Etude longitudinale de la névralgie cervico-brachiale dans le service de neurologie du CHU Gabriel Touré, Bamako (Mali)

Introduction: La Névralgie Cervico-Brachiale (NCB) est une pathologie relativement fréquente dans la pratique courante. Elle est pourvoyeused'importants coûts médicaux et socio-économiques. Peu de données existent sur la NCB en Afrique.Méthodes: Il s'agit d'une étude longitudinale, descriptive et prospective qui s'est déroulée du 1er novembre 2009 au 30 Août 2010 au CHU Gabriel Touré de Bamako, Mali. Elle a pour objectif d'étudier les caractéristiques épidémiologiques et cliniques de la NCB. Le diagnostic à été strictement clinique, et la DN4 a permis de déterminer les caractéristiques de cette névralgie. L´intensité de la douleur a été évaluée par l'échelle verbale simple (EVS).L'échelle concis de la douleur et l'échelle HAD ont permis d'étudier l'impact de la douleur sur la qualité de vie des patients. Résultats: La fréquence de la NCB est de 10,9%.Les ménagères sont les plus touchées, 21(40,4%). L'âge moyen des patients est de 48 ±7 ans. La tranche d'âge de 50-59 ans représente la classe modale. La douleur est à prédominance nocturne chez 75,0% des patients. Les décharges  électriques sont la caractéristique principale soit 48,1% des patients et 57,7% malades présentent une douleur intense. Sur le plan  topographique, la racine C7, est la plus atteinte soit 50,0%. Sur la qualité de la vie, 44,2% des malades présentent des troubles du sommeil. Sur le plan thérapeutique l'évolution a été favorable chez 78,8% des patients sous AINS, Tramadol et Amitriptilline. Conclusion: otre travail à l'instar des études antérieures sur la NCB montre que cette pathologie reste une entité clinique relativement courante. Le pronostic généralement favorable est fonction d'un diagnostic précoce et d'une prise en charge adaptée

Evolving quality standards for large-scale registries: the GARFIELD-AF experience.

Aims: Registries have the potential to capture treatment practices and outcomes in populations beyond the constraints of clinical trial settings. The value of data obtained depend critically upon robust quality standards (including source data verification [SDV] and training); features that are commonly absent from registries. This article outlines the quality standards developed for Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF). Methods and Results: GARFIELD-AF comprises ∼57 000 patients prospectively recruited over 6.5 years in 35 countries in five successive cohorts. The registry employs a combination of remote and onsite monitoring to ascertain completeness and accuracy of records and by design, SDV is performed on 20% of cases (i.e. ∼11 400 patients). Four performance measures for ranking sites according to data quality and other performance indicators were evaluated (including data quality for 13 quantifiable variables, late data locking, number of missing critical variables, and history of poor data quality from the previous monitoring phase). These criteria facilitated the identification of sites with potentially suboptimal data quality for onsite monitoring. During early phases of the registry, critical variables for data checking were also identified. SDV using these variables (partial SDV in 902 patients) showed similar concordance to SDV of all fields (110 patients): 94.4% vs. 93.1%, respectively. This standard formed the baseline against which ongoing quality improvements were assessed, facilitating corrective action on data quality issues. In consequence, concordance was improved in the next monitoring phase (95.6%; n = 1172). Conclusion: The quality standards in GARFIELD-AF have the potential to inform a future 'reference' for registries

MORBIDITE ET MORTALITE CHEZ LES ENFANTS DE 01 A 59 MOIS HOSPITALISES AU SERVICE DE PEDIATRIE GENERALE DU CHU GABRIEL TOURE DE JANVIER A DECEMBRE 2013

Objectif : Ce travail visait à étudier la morbidité et la mortalité chez les enfants âgés de 01 à 59 mois hospitalisés dans le service de pédiatrie générale du CHU Gabriel Touré. Matériels et Méthodes : Il s’agissait d’une étude rétrospective, descriptive, sur une période de 12 mois allant du 1er janvier au 31 décembre 2013. Résultats : Nous avons inclus 1625 enfants âgés de 01 à 59 mois soit 58% des patients hospitalisés. Le tiers des patients avait moins d’un an. Les garçons représentaient 57 % de notre échantillon avec un sex ratio de 1,33. La majorité des patients (83%) était issu de milieu social défavorisé. Les principaux diagnostics retrouvés étaient le paludisme (45%), les infections respiratoires aiguës (20,30%), et la malnutrition aiguë sévère (20,06%). Les patients guéris représentaient 82,3% et le taux de mortalité était estimé à 3,3%. La majorité des patients décédés était des filles (51%). Les décès étaient plus fréquents en juillet et aout. Les trois principales causes de décès étaient la malnutrition (47%), le paludisme (32%) et les infections respiratoires aigües (19%). Nous avons enregistré 48 sorties contre avis médical (3%) et 81 cas d’évasion (5%). Conclusion : La morbidité et la mortalité en pédiatrie restent préoccupantes dans notre pratique. Elles sont liées à des affections pour la plupart évitables par l’information, l’éducation et la communication

Relation entre Maladies Parodontales et Maladies cardiovasculaires : Revue de la littérature

Introduction : La maladie parodontale (MP) est une maladie inflammatoire complexe qui détruit les tissus de soutien de la dent (parodonte) avec une étiologie multifactorielle elle a été liée au diabète, aux obstructions chroniques des voies respiratoires, aux maladies rénales chroniques, aux syndromes métaboliques, à certains types de cancers, la polyarthrite rhumatoïde et aux maladies cardiovasculaires. Les maladies cardiovasculaires (MCV) constituent un ensemble de troubles affectant le cœur et les vaisseaux sanguins, leur cause la plus courante est l’athérosclérose, qui correspond à un remaniement pathologique de la paroi interne des artères de gros et moyen calibres par accumulation de lipides, glucides complexes, éléments sanguins et dépôts calcaires, formant des plaques d’athérosclérose. Ainsi, l’objectif de cette revue de la littérature est de déterminer la relation entre les maladies parodontales et les maladies cardiovasculaires. Matériels et Méthodes : Pour ce travail une stratégie de recherche documentaire électronique a été réalisée dans 2 bases de données dont Pub Med et Google scholar. Ainsi 423 articles traitant la relation entre les maladies parodontales et les maladies cardiovasculaires publiés en anglais ou en français avec texte intégral dans la période allant de 1989 à 2016 ont été sélectionnés. Les titres et résumés des articles retrouvés grâce à la stratégie de recherche ont été passés en revue. Les articles qui n’étaient pas pertinents pour une inclusion ont été écartés dès ce stade. Les données recueillies ont subi une analyse après mise en œuvre des critères d’inclusions : Etudes réalisées chez les humains et rédigées en anglais ou en français et publiés entre 1989 à 2016. Les articles inclus étaient ceux après lecture des titres, des résumés jugés pertinents dont 35 articles traitant la relation entre les maladies parodontales et les Maladies Cardiovasculaires ont été sélectionnés. Résultat : Au total 35 articles traitant la relation entre les maladies parodontales et les Maladies cardiovasculaires ont été sélectionnés compte tenu de leurs cohérence et pertinence. La limite a été la consultation que de 2 bases de données. Les bactériémies associées aux parodontites sont responsables d’une activation de la réponse immuno-inflammatoire favorisant la formation, la maturation et la complication des plaques d’athérome. Il existe un risque accru de MCV chez les patients atteints de parodontite chronique, indépendamment des autres facteurs de risques cardiovasculaires. Le traitement parodontal réduit le niveau d’inflammation systémique et améliore la fonction endothéliale, mais ne modifie pas la dyslipidémie. Conclusion : avec une étiologie infectieuse pour les maladies et divers pour les maladies cardiovasculaires, un lien a été établi entre les deux maladies dans diverses études épidémiologiques et cliniques mais toutes fois reste controverse dans d’autre

Diagnostic and prognostic utility of an inexpensive rapid on site malaria diagnostic test (ParaHIT f) among ethnic tribal population in areas of high, low and no transmission in central India

BACKGROUND: Malaria presents a diagnostic challenge in most tropical countries. Rapid detection of the malaria parasite and early treatment of infection still remain the most important goals of disease management. Therefore, performance characteristics of the new indigenous ParaHIT f test (Span diagnostic Ltd, Surat, India) was determined among ethnic tribal population in four districts of different transmission potential in central India to assess whether this rapid diagnostic test (RDT) could be widely applied as a diagnostic tool to control malaria. Beyond diagnosis, the logical utilization of RDTs is to monitor treatment outcome. METHODS: A finger prick blood sample was collected from each clinically suspected case of malaria to prepare blood smear and for testing with the RDT after taking informed consent. The blood smears were read by an experienced technician blinded to the RDT results and clinical status of the subjects. The figures for specificity, sensitivity, accuracy and predictive values were calculated using microscopy as gold standard. RESULTS: The prevalence of malaria infection estimated by RDT in parallel with microscopy provide evidence of the type of high, low or no transmission in the study area. Analysis revealed (pooled data of all four epidemiological settings) that overall sensitivity, specificity and accuracy of the RDT were >90% in areas of different endemicity. While, RDT is useful to confirm the diagnosis of new symptomatic cases of suspected P. falciparum infection, the persistence of parasite antigen leading to false positives even after clearance of asexual parasitaemia has limited its utility as a prognostic tool. CONCLUSION: The study showed that the ParaHIT f test was easy to use, reliable and cheap. Thus this RDT is an appropriate test for the use in the field by paramedical staff when laboratory facilities are not available and thus likely to contribute greatly to an effective control of malaria in resource poor countries

Geographical and temporal distribution of human giardiasis in Ontario, Canada

BACKGROUND: Giardia is the most frequently identified intestinal parasite in North America. Although information on geographical distribution of giardiasis is critical in identifying communities at high risk, little has been done in this area. Therefore, the objective of this study was to investigate the geographical and temporal distribution of human giardiasis in Ontario in order to identify possible high risk areas and seasons. Two spatial scales of analyses and two disease measures were used with a view to identifying the best of each in assessing geographical patterns of giardiasis in Ontario. Global Moran's I and Moran Local Indicators of Spatial Associations were used to test for evidence of global and local spatial clustering, respectively. RESULTS: There were seasonal patterns with summer peaks and a significant (P < 0.001) decreasing temporal trend. Significant (P < 0.05) global spatial clustering of high rates was observed at the Census Sub-division spatial scale but not at the Census Division scale. The Census Sub-division scale was a better scale of analyses but required spatial empirical Bayesian smoothing of the rates. A number of areas with significant local clustering of giardiasis rates were identified. CONCLUSIONS: The study identified spatial and temporal patterns in giardiasis distribution. This information is important in guiding decisions on disease control strategies. The study also showed that there is benefit in performing spatial analyses at more than one spatial scale to assess geographical patterns in disease distribution and that smoothing of disease rates for mapping in small areas enhances visualization of spatial patterns

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso

In Burkina Faso, onchocerciasis was no longer a public health problem when the WHO Onchocerciasis Control Programme in West Africa closed at the end in 2002. However, epi-demiological surveillance carried out from November 2010 to February of 2011, showed a recrudescence of infection in the Cascades Region. This finding was made at a time when ivermectin, a drug recommended for the treatment of both onchocerciasis and lymphatic fila-riasis, had been distributed in this area since 2004 for the elimination of lymphatic filariasis. It was surprising that ivermectin distributed for treating lymphatic filariasis had not prevented the recrudescence of onchocerciasis. Faced with this situation, the aim of our study was to evaluate the effectiveness of ivermectin on the onchocerciasis parasite. The percentage reduction in microfilarial load after treatment with ivermectin was used as a proxy measure for assessing possible resistance. A cohort study was carried out with 130 individuals who had tested positive for microfilariae of Onchocerca volvulus in 2010 using microscopic examination of skin-snip biopsies from five endemic villages. Subjects were followed from July 2011 to June 2012. The microfilarial load of each individual was enumerated by skin-snip biopsy in 2010, prior to the first ivermectin treatment against onchocerciasis under community guidelines. All individuals received two ivermectin treatments six months apart. In 2012, the microfilarial loads were determined again, six months after the second round of ivermectin and the reductions in parasite loads were calculated to measure the impact of the drug. The percentage reduction of the microfilarial loads ranged from 87% to 98% in the vil-lages. In all villages, there was a statistically significant difference between the average microfilarial loads in 2010 and 2012. The level of reduction of microfilarial loads suggests that ivermectin is effective against the recrudescent population of O. volvulus in Cascades Region of Burkina Faso. Further investigations would be necessary to determine the causes of the recrudescence of onchocerciasis. (For French language abstract, see S1 Alternative Language Abstract—Translation of the Abstract into French by the authors.)

QUARITE (quality of care, risk management and technology in obstetrics): a cluster-randomized trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali

<p>Abstract</p> <p>Background</p> <p>Maternal and perinatal mortality are major problems for which progress in sub-Saharan Africa has been inadequate, even though childbirth services are available, even in the poorest countries. Reducing them is the aim of two of the main Millennium Development Goals. Many initiatives have been undertaken to remedy this situation, such as the Advances in Labour and Risk Management (ALARM) International Program, whose purpose is to improve the quality of obstetric services in low-income countries. However, few interventions have been evaluated, in this context, using rigorous methods for analyzing effectiveness in terms of health outcomes. The objective of this trial is to evaluate the effectiveness of the ALARM International Program (AIP) in reducing maternal mortality in referral hospitals in Senegal and Mali. Secondary goals include evaluation of the relationships between effectiveness and resource availability, service organization, medical practices, and satisfaction among health personnel.</p> <p>Methods/Design</p> <p>This is an international, multi-centre, controlled cluster-randomized trial of a complex intervention. The intervention is based on the concept of evidence-based practice and on a combination of two approaches aimed at improving the performance of health personnel: 1) Educational outreach visits; and 2) the implementation of facility-based maternal death reviews.</p> <p>The unit of intervention is the public health facility equipped with a functional operating room. On the basis of consent provided by hospital authorities, 46 centres out of 49 eligible were selected in Mali and Senegal. Using randomization stratified by country and by level of care, 23 centres will be allocated to the intervention group and 23 to the control group. The intervention will last two years. It will be preceded by a pre-intervention one-year period for baseline data collection. A continuous clinical data collection system has been set up in all participating centres. This, along with the inventory of resources and the satisfaction surveys administered to the health personnel, will allow us to measure results before, during, and after the intervention. The overall rate of maternal mortality measured in hospitals during the post-intervention period (Year 4) is the primary outcome. The evaluation will also include cost-effectiveness.</p> <p>Trial Registration</p> <p>The QUARITE trial is registered on the Current Controlled Trials website under the number ISRCTN46950658 <url>http://www.controlled-trials.com/</url>.</p

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial

<p>Abstract</p> <p>Background</p> <p>Even though the efficacy of Intermittent Preventive Treatment in infants (IPTi) with Sulfadoxine-Pyrimethamine (SP) against clinical disease and the absence of its interaction with routine vaccines of the Expanded Immunization Programme (EPI) have been established, there are still some concerns regarding the addition of IPTi, which may increase the work burden and disrupt the routine EPI services especially in Africa where the target immunization coverage remains to be met. However IPTi may also increase the adherence of the community to EPI services and improve EPI coverage, once the benefice of strategy is perceived.</p> <p>Methods</p> <p>To assess the impact of IPTi implementation on the coverage of EPI vaccines, 22 health areas of the district of Kolokani were randomized at a 1:1 ratio to either receive IPTi-SP or to serve as a control. The EPI vaccines coverage was assessed using cross-sectional surveys at baseline in November 2006 and after one year of IPTi pilot-implementation in December 2007.</p> <p>Results</p> <p>At baseline, the proportion of children of 9-23 months who were completely vaccinated (defined as children who received BGG, 3 doses of DTP/Polio, measles and yellow fever vaccines) was 36.7% (95% CI 25.3% -48.0%). After one year of implementation of IPTi-SP using routine health services, the proportion of children completely vaccinated rose to 53.8% in the non intervention zone and 69.5% in the IPTi intervention zone (P <0.001).</p> <p>The proportion of children in the target age groups who received IPTi with each of the 3 vaccinations DTP2, DTP3 and Measles, were 89.2% (95% CI 85.9%-92.0%), 91.0% (95% CI 87.6% -93.7%) and 77.4% (95% CI 70.7%-83.2%) respectively. The corresponding figures in non intervention zone were 2.3% (95% CI 0.9% -4.7%), 2.6% (95% CI 1.0% -5.6%) and 1.7% (95% CI 0.4% - 4.9%).</p> <p>Conclusion</p> <p>This study shows that high coverage of the IPTi can be obtained when the strategy is implemented using routine health services and implementation results in a significant increase in coverage of EPI vaccines in the district of Kolokani, Mali.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov <a href="http://www.clinicaltrials.gov/ct2/show/NCT00766662">NCT00766662</a></p

Continuous and transparent multimodal authentication: reviewing the state of the art

Individuals, businesses and governments undertake an ever-growing range of activities online and via various Internet-enabled digital devices. Unfortunately, these activities, services, information and devices are the targets of cybercrimes. Verifying the user legitimacy to use/access a digital device or service has become of the utmost importance. Authentication is the frontline countermeasure of ensuring only the authorized user is granted access; however, it has historically suffered from a range of issues related to the security and usability of the approaches. They are also still mostly functioning at the point of entry and those performing sort of re-authentication executing it in an intrusive manner. Thus, it is apparent that a more innovative, convenient and secure user authentication solution is vital. This paper reviews the authentication methods along with the current use of authentication technologies, aiming at developing a current state-of-the-art and identifying the open problems to be tackled and available solutions to be adopted. It also investigates whether these authentication technologies have the capability to fill the gap between high security and user satisfaction. This is followed by a literature review of the existing research on continuous and transparent multimodal authentication. It concludes that providing users with adequate protection and convenience requires innovative robust authentication mechanisms to be utilized in a universal level. Ultimately, a potential federated biometric authentication solution is presented; however it needs to be developed and extensively evaluated, thus operating in a transparent, continuous and user-friendly manner